Lessons From GAMP 5
Software selection, implementation, and ongoing maintenance are critical stages in the life cycle of biomedical software systems such as asset and calibration management platforms.
Software selection, implementation, and ongoing maintenance are critical stages in the life cycle of biomedical software systems such as asset and calibration management platforms.
At Ramirez & Co., a midsize business with decades of wins, leadership thought its biggest challenges were competitors, technology, and the market. Close, but no cigar.
What if your quality system could detect and initiate corrective actions for equipment deviations before they affect product quality?
Imagine you’re a student trying to pass a challenging class, one where the entire grade rests on the big test at the end of the semester. Fortunately, the professor handed out a syllabus that outlines exactly what will be on that final exam.
Take two aspirin and call me in the morning: If only prescribing medications were as simple as that.
NIST researcher Kamran Sayrafian developed a computational model of the lungs with different levels of excess fluid. The long-term goal is to develop a device that could alert the patient or medical provider when it detects pulmonary edema in the user’s lungs.
A few years ago, I heard on the news that many people were being hospitalized with a condition of excess fluid in the lungs, called pulmonary edema.
A student at the University of Perugia 3D scanning an implant with Artec Micro II.
The dental industry is seeing a surge in 3D printing, with the technology enabling a growing number of dentists to rapidly create custom implants in clinics around the world.
Lasers enable safe, scratch-resistant marking that’s more durable than ever.
In medical technology, safety is paramount. Every step in the manufacturing process must meet the highest standards, from patient protection to regulatory compliance.
A team of NIST researchers, including Srivalli Telikepalli (shown here), developed a standard reference material that will help biopharmaceutical companies better detect these particles in their drug products.
A rapidly growing category of drugs called protein-based biotherapeutics can be used to treat cancers and genetic and autoimmune disorders.
Pharmaceutical serialization practices are on the rise and have progressively become a worldwide standard as a result of stringent regulations in various of markets, including the United States, European Union, China, and Argentina.
© 2025 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute Inc.